0000000000709555
AUTHOR
M. Ventura
Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis
Objectives: We investigated clinical correlates of atrial fibrillation (AF) progression and evaluated the prognosis of patients demonstrating AF progression in a large population. Background: Progression of paroxysmal AF to more sustained forms is frequently seen. However, not all patients will progress to persistent AF. Methods: We included 1,219 patients with paroxysmal AF who participated in the Euro Heart Survey on AF and had a known rhythm status at follow-up. Patients who experienced AF progression after 1 year of follow-up were identified. Results: Progression of AF occurred in 178 (15%) patients. Multivariate analysis showed that heart failure, age, previous transient ischemic attac…
M-App & Health Knowledge Management – Virtual Artfacts between Doctor & Patient
Knowledge is more and more a strategic resource for health or- ganizations while information and communication technology earns an important role for sharing knowledge and informations among people in and out organizations. These conditions satisfy specific demands related to the new emerging information needs, asking for a change in relation- ships and effective communication. So, the Medicine Apps represent an emerging and rapidly developing framework for health system, able to contribute to its quality and efficiency. The same Union European and U.S. Supervisory Authority activated in the last years an appropriate study in order to control the Medical Applications downloaded directly thr…
Adherence issues related to sublingual immunotherapy as perceived by allergists.
Silvia Scurati1, Franco Frati1, Gianni Passalacqua2, Paola Puccinelli1, Cecile Hilaire1, Cristoforo Incorvaia3, Italian Study Group on SLIT Compliance 1Scientific and Medical Department, Stallergenes, Milan, Italy; 2Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa; 3Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, ItalyObjectives: Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered…
Performance organizzativa e carichi di lavoro nello studio sui Consorzi Regionali di Bonifica
The objective of our research was to verify, through an empirical survey, the measuring of the relationship between workload and performance within complex public organizations. Starting from the reference literature the research approach adopted was of a mixed type characterized by an exploratory design and the analysis of a case study. #e data collection was carried out through documentary sources and some structured interviews administered to the management and the various sector heads of reclamation consortium studied. Based on the interviews carried out, a relationship between the measurement of the workload and the performance within the institution examined is inferred, because there…
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, RealWorld Study
Introduction: In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Most real-world research on BRV has focused on refractory epilepsy. The aim of this analysis was to assess the 12-month effectiveness and tolerability of adjunctive BRV when used as early or late adjunctive treatment in patients included in the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST). Methods: BRIVAFIRST was a 12-month retrospective, multicenter study including adult patients prescribed adjunctive BRV. Effectiveness outcomes included the rates of sustained seizure response, sustained seizure freedom, and treatment discontinua…
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
Background: In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Studies performed in a naturalistic setting are a useful complement to characterize the drug profile. Objective: This multicentre study assessed the effectiveness and tolerability of adjunctive BRV in a large population of patients with focal epilepsy in the context of real-world clinical practice. Methods: The BRIVAFIRST (BRIVAracetam add-on First Italian netwoRk STudy) was a retrospective, multicentre study including adult patients prescribed adjunctive BRV. Patients with focal epilepsy and 12-month follow-up were considered. Main outcomes includ…
CCDC 795476: Experimental Crystal Structure Determination
Related Article: M.Ventura, C.R.de Arellano, M.E.G.Mosquera, G.Jimenez, T.Cuenca|2011|Dalton Trans.|40|5728|doi:10.1039/c0dt01393e
CCDC 795475: Experimental Crystal Structure Determination
Related Article: M.Ventura, C.R.de Arellano, M.E.G.Mosquera, G.Jimenez, T.Cuenca|2011|Dalton Trans.|40|5728|doi:10.1039/c0dt01393e